Skip to the content

Whatsapp: +8801721-910505

DrugcenDrugcen
  • Home
  • Brands
    • Beacon
    • Drug international
    • Everest
    • General
    • Incepta
    • Ziska pharma
  • Categories
    • Lung Cancer
    • Blood cancer
    • Breast cancer
    • Prostate Cancer
    • Kidney cancer
    • Covid-19
  • Online Pharmacy
  • About Us
  • Contact Us
  • Blog
  • Home
  • Brands
    • Beacon
    • Drug international
    • Everest
    • General
    • Incepta
    • Ziska pharma
  • Categories
    • Lung Cancer
    • Blood cancer
    • Breast cancer
    • Prostate Cancer
    • Kidney cancer
    • Covid-19
  • Online Pharmacy
  • About Us
  • Contact Us
  • Blog
Home / Drug international / Elopag 50 Mg (Eltrombopag)
Elopag 50 Mg (Eltrombopag)

Elopag 50 Mg (Eltrombopag)

Elopag 50 Mg (Eltrombopag) is a medication prescribed to treat low platelet counts in individuals with certain medical conditions. It stimulates platelet production in the bone marrow, reducing the risk of bleeding and bruising. Common side effects may include headache, nausea, fatigue, and muscle pain. Dosage should be determined by a healthcare professional.

Product Name: Elopag 50 Mg

Generic Name: Eltrombopag

Most Related Products: Elbonix 50mg   Elbonix 25 Mg

 

Category: Drug international Tags: Elopag 50 Mg, Elopag 50 Mg (Eltrombopag), Elopag 50 Mg review
  • Description
  • Reviews (0)

Description

Elopag 50 Mg (Eltrombopag)

Elopag 50 Mg (Eltrombopag) is a medication primarily used to treat low platelet counts in individuals with certain medical conditions. It belongs to a class of drugs known as thrombopoietin receptor agonists. Elopag works by stimulating the production of platelets in the bone marrow, thereby increasing their numbers in the blood. This medication is commonly prescribed for patients with chronic immune thrombocytopenia (ITP) or hepatitis C-related thrombocytopenia. By boosting platelet levels, Elopag helps reduce the risk of bleeding and bruising associated with low platelet counts. It is important to follow the dosage instructions provided by healthcare professionals and be aware of potential side effects, which may include headache, nausea, and fatigue.

Side Effects

  • Headache
  • Nausea
  • Fatigue
  • Diarrhea
  • Muscle or joint pain
  • Dizziness
  • Changes in taste
  • Tingling or numbness in the hands or feet
  • Insomnia or trouble sleeping
  • Increased risk of blood clots (rare)

It is important to note that not everyone will experience these side effects, and some individuals may experience different or additional side effects. It is recommended to consult with a healthcare professional for more detailed information about the potential side effects of Elopag 50 mg (Eltrombopag) based on your specific medical condition and personal health history.

STORAGE

Elopag 50 Mg needs to be kept cool (below 30 degrees Celsius), dark (away from light), and secure location (away from curious hands).

Reviews

There are no reviews yet.

Be the first to review “Elopag 50 Mg (Eltrombopag)” Cancel reply

Your email address will not be published. Required fields are marked *

Related products

  • Rutinib Cream

    Rutinib Cream (Ruxolitinib)

    Order Now
  • latinib

    Latinib 250 Mg (Lapatinib)

    Order Now
  • palbo-125mg

    Palbo 125 Mg (Palbociclib)

    Order Now
  • butinib

    Butinib ( Ibrutinib 140 Mg )

    Order Now

Drugcen provides generic medicines that have been recently approved worldwide. All types of anti-cancer medicine (Oncology) are available from us. We aim to provide medical support at an affordable price and quality is our responsibility, so you don't have to worry about the quality of our medicines.

Information

  • Home
  • Blog
  • Privacy Policy
  • Terms & Conditions

Categories

  • Blood cancer
  • Breast cancer
  • Kidney cancer
  • Lung Cancer
  • Prostate Cancer

Our services

  • Beacon
  • Drug international
  • Everest
  • General
  • Incepta
  • Ziska pharma

Socials

  • Facebook
  • Twitter
  • Instagram
  • Linkedin

Copyright © 2022 Drugcen. All Rights Reserved.

Up ↑ Up ↑